Status:
UNKNOWN
Nexplanon Removal: Subcutaneous vs. Topical Lidocaine
Lead Sponsor:
Augusta University
Conditions:
Contraception
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
A randomized trial of using EMLA cream for anesthesia to remove Nexplanon versus the standard route of subcutaneous lidocaine for anesthesia. Primary endpoints are pain during procedure and time to re...
Eligibility Criteria
Inclusion
- Females with Nexplanon implant in place, desiring removal No allergy to lidocaine or any component of EMLA cream Age greater than or equal to 18years English as primary language Not pregnant
Exclusion
- pregnant non-emglish speaking age less than 18 yo Allergy to lidocaine or EMLA
Key Trial Info
Start Date :
January 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04467125
Start Date
January 6 2020
End Date
May 31 2023
Last Update
July 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Augusta University Ob/Gyn Resident Continuity Clinic
Augusta, Georgia, United States, 30912